These 5 companies will have minimal impact from the tariffs and could deliver strong results in 2025.

ZM is continuously upgrading its AI Companion by adding Agentic AI solutions. which investors can see as a compelling entry point now.

JPM will release Q1 earnings next week. Here, we explore the factors influencing its performance and check whether the stock merits a place in your portfolio.

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your enCore Energy Corp. (NASDAQ:EU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/encore-energy-corp-lawsuit-submission-form?prid=141073&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. (NASDAQ:SANA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sana-biotechnology-inc-lawsuit-submission-form?prid=141069&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Quantum Computing Inc. (NASDAQ:QUBT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/quantum-computing-inc-lawsuit-submission-form?prid=141070&wire=1 or contact Joseph E. Levi, Esq.

Best Buy Co., Inc. BBY shares are lower again Friday. This comes after yesterday's drop of almost 18%.

Despite federal workforce layoffs, Elme's limited exposure to federal jobs and strong portfolio fundamentals, including high occupancy and rent growth, support its stability. Management anticipates steady revenue and expense growth, with additional NOI expected from managed Wi-Fi initiatives and operational cost savings. Given current economic uncertainties and Elme's fair valuation, I recommend a 'Hold' on the stock until a more attractive entry point around a 15x P/FFO range.

GM CEO Mary Barra hinted at this shift during an earnings call earlier this year, emphasizing the company's capacity to adapt.

Nvidia Corp.'s stock continues to get slammed, with a 13.7% weekly decline putting it on pace for its worst such drop since January. That was when DeepSeek made investors question whether massive spending on artificial intelligence was sustainable.

CSX's focus on enhancing workplace safety for its employees is commendable.

GRMN is well-positioned for sustained growth due to its continuous product innovation, which investors can see as a compelling entry point in 2025.

Volatility has soared to the highest level since August. Investors can benefit from this trend with ETF/ETN options available in the market.

Nvidia (NVDA) gets 40% of its business from Asia, Tesla (TSLA) gets 22% of its revenue from China, and Apple (AAPL) added exposure to international markets. Jenny Horne talks about the potential for tariffs to etch more weakness into the stock market's leaders.

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Alarum Technologies Ltd. (NASDAQ:ALAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/alarum-technologies-ltd-lawsuit-submission-form?prid=141067&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your e.l.f. Beauty, Inc. (NYSE:ELF) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/e-l-f-beauty-lawsuit-submission-form?prid=141068&wire=1 or contact Joseph E.

SAN FRANCISCO, CA / ACCESS Newswire / April 4, 2025 / A securities class action lawsuit, captioned Abramov v. Fluence Energy, Inc., et al.

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/maravai-lifesciences-holdings-inc-lawsuit-submission-form?prid=141072&wire=1 or contact Joseph E. Levi, Esq.

SAN FRANCISCO, CA / ACCESS Newswire / April 4, 2025 / On March 27, 2025, investors in AppLovin (NASDAQ:APP) saw the price of their shares drop $65.92, wiping out about $20 billion of the company's market value, after prominent short seller Muddy Waters Research revealed its short position in the stock. Muddy Waters' report comes on the heels of a recently filed securities class action lawsuit, captioned Quiero v.

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Geron Corporation (NASDAQ:GERN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/geron-corporation-lawsuit-submission-form?prid=141066&wire=1 or contact Joseph E. Levi, Esq.